Locations:
SearchAdvertisement
Switching medications may decrease treatment burden and macular fluid
Advanced OCT features may help individualize treatment intervals
53% of participants didn’t need anti-VEGF for six months or longer
Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patients with diabetic eye disease are most affected
Studies evaluate patients who missed treatments for diabetic macular edema and neovascular age-related macular degeneration
Greater durability of action also allows spacing of doses
Advertisement
Advertisement